Full-year 2026 revenue guidance of $16 million to $18 million was reaffirmed, assuming the challenging NIH funding ...

The average one-year price target for Seer (NasdaqGS:SEER) has been revised to $4.08 / share. This is an increase of 33.33% ...

Seer (NASDAQ:SEER) reported lower first-quarter revenue but reaffirmed its full-year 2026 outlook, with management pointing ...

2026 Guidance Seer continues to expect full year 2026 revenue to be in the range of $16 million to $18 million, representing growth of 3% at the midpoint over full year 2025.

Thank you, Marissa, and thank you all for joining us this afternoon. At Seer, we're making significant progress on our innovation road map, commercial position and strategic objectives as we start the ...

Life-sciences company Seer's minority shareholders again sweetened their offer to take the company private, in their third such proposal in about a month. Bradley Radoff and Michael Torok, who ...

Seer, Inc. () has held its Q4 earnings call. Read on for the main highlights of the call. Claim 50% Off TipRanks Premium. Unlock hedge fund-level data and powerful investing tools ...

Perella Weinberg Partners LP is serving as financial advisor to Seer, and Wilson Sonsini Goodrich & Rosati, Professional Corporation is serving as legal counsel. In other recent news, Seer, Inc.

Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the first quarter 2026 on Wednesday, May 13, ...